Over 23 years of experience in infectious diseases, vaccines, market access and health policy.
✓ Former Director of Market Access & Policy Affairs, Moderna UK & Ireland
✓ Previous Senior Leadership roles at SPMSD, Sanofi and Biogen
✓ Former Member of the National Institute for Health and Care Excellence (NICE) and the New Drugs Committee (NDC) for the Scottish Medicines Consortium (SMC)
✓ Former Senior Expert Adviser, UK Government (Vaccines Taskforce) and Cllr and Cabinet Member Adult Social Care, Health and Children's Services (2015-2023)
✓ Author of 180+ peer reviewed papers
✓ Honorary Assistant Professor at University of Nottingham and Fellow of Royal Societies of Public Health, Arts and Medicine
✓ Chairman of the Conservative Party Health Policy Forum and Expert Adviser on Welfare, Northern Ireland and the ECHR
✓ Expert in welfare policy, Equality Act, the Good Friday Agreement and Irish politics
✓ Specialising in biosecurity policy, research and defence economics
Stuart Carroll is a senior health economist and epidemiologist with over 23 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public health, and public affairs and government policy. He recently worked for Moderna as Director of Market Access and Policy Affairs, Moderna UK and Ireland for four years where he also helped negotiate the UK Government's Strategic Partnership for pandemic preparedness. He previously worked for Her Majesty’s Government as a Senior Expert Policy and Strategy Adviser for the Prime Minister’s UK Vaccines Taskforce and the Antiviral and Therapeutics Taskforce where he was responsible for coordinating strategy on deployment and implementation imperatives as well as providing expert advice on supply and procurement to the Joint Committee on Vaccination and Immunisation (JCVI) and leading on the Northern Ireland Protocol and assisting with drafting the Windsor Framework. Stuart also specialises in health policy and market access matters relating to rare diseases, neurology and mental health, and has published over 180 peer review academic and scientific papers.
Previously, Stuart has worked in consultancy, acted as a Health Policy Adviser to the Conservative Party and undertaken multiple industry roles including as Head of Market Access and Public Affairs for Sanofi Pasteur UK and Ireland and previously Head of Market Access for Biogen and Head of Health Economics and Epidemiology for Sanofi Pasteur MSD. He has also served as a full voting member of the New Drugs Committee to the Scottish Medicines Consortium and a member of the National Institute for Health and Care Excellence Appeals Panel. He is a Fellow of The Royal Society for Public Health and Royal Society of Arts, a Senior Fellow at Policy Exchange and the Office of Health Economics. Stuart has previously acted as visiting lecturer to Imperial Business School. He is currently the Co-Chair of the Association of the British Pharmaceutical Industry Vaccines Group and in 2019 General Election acted as the former Prime Minister, Theresa May’s Chief of Staff.
Stuart holds a BA (Hons) in Politics and Economics (1st Class) from the University of Northumbria at Newcastle, an MSc in Health Economics (Distinction) from the University of York, and an MBA (Distinction) from Imperial Business School. He is currently completing a PhD in public health and public policy at the University of Nottingham.
Stuart also served as an elected councillor where he represented Boyn Hill in the Royal Borough of Windsor, Ascot and Maidenhead between 2015-2023 and also served as the Deputy Chair of Cabinet, the Cabinet Member for Adult Social Care, Health, Mental Health and Children’s Services and the Chairman of the Health and Wellbeing Board. He has extensive experience across public and government affairs including communications strategy.
Stuart was appointed an Honorary Assistant Professor at the University of Nottingham in April 2026 in the School of Medicine where his research and teaching focuses on public health, vaccination, pandemic preparedness and health economic applications.
← Go Back